Sakai, Shuhei
Kobuchi, Shinji
Ito, Yukako
Sakaeda, Toshiyuki
Article History
Accepted: 22 January 2021
First Online: 19 February 2021
Declarations
:
: This work did not receive special funding.
: SS, SK, YI, and TS have no conflict of interests to declare.
: All experimental procedures using animals were approved by an institutional review board and performed per the Kyoto Pharmaceutical University Guidelines for Animal Experimentation.
: Non-compartment analysis and modeling were performed with Phoenix WinNonlin<sup>®</sup> software (version 6.4, Certara USA, Inc., Princeton, NJ, USA)
: TS conceptualization; SS, SK, and YI methodology; SS, SK, and YI formal analysis and investigation; SS writing original draft; SK, YI, and TS review and editing the original draft; and TS supervision.